US 8,148,334 B2 · Peptides with capacity for binding with interleukine 10 (IL-10)

Peptides with capacity for binding with interleukine 10 (IL-10)

AssigneeProyecto De Biomedicina Cima, S.L.

InventorsLorea Manterola Careaga, Inés Noelia Casares Lagar, Nancy Díaz-Valdés Farray, Javier Dotor de las Herrerías, Juan José Lasarte Sagastibelza, Pablo Sarobe Ugarriza, Jesús Prieto Valtueñ, Francisco Borrás Cuesta

Life of this patent

Estimating the term…

Abstract

The invention relates to peptides having the capacity to bind to interleukin-10 (IL-10) and their use in the treatment of clinical conditions or pathological disorders associated to IL-10 expression, particularly to a high IL-10 expression, for example, infectious diseases, tumors, cancers and acute damage conditions.

Claims13

Dependent claims

A peptide comprising 12, 13, 14, or 15 consecutive amino acids of SEQ ID NO:

6, or a pharmaceutically acceptable salt thereof, wherein said peptide has the capacity to bind to IL-10.

Dependencies are inferred from the claim text.

Facts

Application

12/593,321Filed 27 Mar 2008

Priority

ES 20070080627 Mar 2007

Published

US 2010/0168015 A11 Jul 2010

Granted

3 Apr 2012

Term ends

Not estimatedThe source records don’t support an estimate.

Classification14 codes

C07K 14/5428
Interleukins [IL]: il-10
A61P 17/02
Drugs for dermatological disorders: for treating wounds, ulcers, burns, scars, keloids, or the like
A61P 31/00
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P 31/04
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antibacterial agents